A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma

Pediatric Dermatology

Volumn 26, Issue 2, 2009, Pages 203-212

  McCuaig, Catherine C ^a,b   Dubois, Josée ^b   Powell, Julie ^b   Belleville, Claude ^b   David, Michèle ^b   Rousseau, Élisabeth ^a   Gendron, Roxanne ^b   Jafarian, Fatemeh ^b   Auger, Isabelle ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FUSIDIC ACID; IMIQUIMOD; PSEUDOMONIC ACID;

ARTICLE; BEDTIME DOSAGE; CANADA; CLINICAL ARTICLE; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOLLOW UP; HEMANGIOMA; HUMAN; INFANT; INFECTION; MALE; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN MANIFESTATION; STAPHYLOCOCCUS INFECTION;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEMANGIOMA; HUMANS; INFANT; INTERFERON-ALPHA; MALE; SKIN NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 65649129285     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00857.x     Document Type: Article

References (39)

1. Bruckner AL, Frieden IJ. Hemangiomas of infancy. J Am Acad Dermatol 2003 48 : 477 493. (Pubitemid 36397008)
2. Dinehart SM, Kincannon J, Geronemus R. Hemangiomas: evaluation and treatment. Dermatol Surg 2001 27 : 475 485. (Pubitemid 32436341)
3. Cohen MM. Vasculogenesis, angiogenesis, hemangiomas, and vascular malformations. Am J Med Genet 2002 108 : 265 274. (Pubitemid 34225885)
4. Vikkula M, Boon LM, Mulliken JB et al. Molecular basis of vascular anomalies. Trends Cardiovasc Med 1998 8 : 281 292. (Pubitemid 28498725)
5. Chang J, Most D, Bresnick S et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 1999 103 : 1 9. (Pubitemid 29018825)
6. Takahashi K, Mulliken JB, Kozakewich HP et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994 93 : 2357 2364. (Pubitemid 24177146)
7. Bielenberg DR, Bucana CD, Sanchez R et al. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int J Oncol 1999 14 : 401 408.
8. Ritter MR, Dorrel MI, Edmonds J et al. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci USA 2002 99 : 7455 7460. (Pubitemid 34568712)
9. Isik FF, Rand RP, Gruss JS et al. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res 1996 61 : 71 76. (Pubitemid 26066031)
10. Dadras SS, North PE, Bertoncini J et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004 17 : 1068 1079. (Pubitemid 39128233)
11. Dosquet C, Coudert MC, Wassef M et al. Importance of bFGF ("basic fibroblast growth factor") for diagnosis and treatment of hemangiomas. Ann Dermatol Venereol 1998 125 : 313 316. (Pubitemid 28248552)
12. Hu Q, Lin X, Shang Q et al. The determination and significance of VEGF in the serum of hemangioma patients. Zhonghua Zheng Xing Wai Ke Za Zhi 2002 18 : 98 100.
13. Chang E, Boyd A, Nelson CC et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997 19 : 237 244. (Pubitemid 27276291)
14. Kapur N, Lambiase P, Rakhit RD et al. Local and systemic expression of basic fibroblast growth factor in a patient with familial glomangioma. Br J Dermatol 2002 146 : 518 522. (Pubitemid 34603829)
15. Sidbury R, Neuschler N, Neuschler E et al. Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol 2003 121 : 1205 1209. (Pubitemid 37430994)
16. Hesling C, D'Incan M, Mansard S et al. In vivo and in situ modulation of the expression of genes involved in metastasis and angiogenesis in a patient treated with topical imiquimod for melanoma skin metastases. Br J Dermatol 2004 150 : 761 767. (Pubitemid 38586231)
17. Frieden IJ, Eichenfield LF, Esterly NB et al. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. J Am Acad Dermatol 1997 37 : 631 637.
18. Frieden IJ. Which hemangiomas to treat - and how? Arch Dermatol 1997 133 : 1593 1595.
19. Edwards L, Ferenczy A, Eron L et al. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol 1998 134 : 25 30.
20. Lebwohl M, Dinehart S, Whiting D et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 2004 50 : 714 721. (Pubitemid 38580548)
21. Geisse J, Caro I, Lindholm J et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004 50 : 722 733. (Pubitemid 38580549)
22. Sauder DN. Imiquimod: modes of action. Br J Dermatol 2003 149 (Suppl. 66 5 8. (Pubitemid 38064505)
23. Hurwitz DJ, Pincus L, Kepper TS. Imiquimod: a topically applied link between innate and acquired immunity. Arch Dermatol 2003 139 : 1347 1350. (Pubitemid 37248285)
24. Schon M, Schon MP. The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr Med Chem 2007 14 : 681 687. (Pubitemid 46477720)
25. Martinez MI, Sanchez-Carpintero I, North PE et al. Infantile hemangioma: clinical resolution with 5% imiquimod cream. Arch Dermatol 2002 138 : 881 884. (Pubitemid 34700733)
26. Hazen PG, Carney JF, Engstrom CW et al. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream. Pediatr Dermatol 2005 22 : 254 256. (Pubitemid 40741266)
27. Welsh O, Olazaran Z, Gomez M et al. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream. J Am Acad Dermatol 2004 51 : 639 642. (Pubitemid 39278088)
28. Ho NT, Lansang P, Pope E. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol 2007 56 : 63 68. (Pubitemid 46016997)
29. Sanchez-Carpintero I, Martinez MI, Mihm MC. Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary disease. J Am Acad Dermatol 2006 55 : 75 79. (Pubitemid 43867036)
30. Harrison LI, Skinner SL, Marbury TC et al. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms. Arch Dermatol Res 2004 296 : 6 11. (Pubitemid 38828417)
31. Myhre PE, Levy ML, Eichenfield LF et al. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of molluscum contagiosum in children. Pediatr Dermatol 2008 25 : 88 95.
32. Levy O, Zarember KA, Roy RM et al. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 2004 173 : 4627 4634. (Pubitemid 39280696)
33. Theos AU, Cummins R, Silverberg NB et al. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis 2004 74 : 134 138, 141-142. (Pubitemid 39207747)
34. Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of molluscum contagiosum in children. Dermatol Online J 2001 7 : 20. (Pubitemid 38956775)
35. Bayerl C, Feller G, Goerdt S. Experience in treating molluscum contagiosum in children with imiquimod 5% cream. Br J Dermatol 2003 149 (Suppl. 66 25 29. (Pubitemid 38064510)
36. Skinner RB, Ray S, Talanin NY. Treatment of molluscum contagiosum with topical 5% imiquimod cream. Pediatr Dermatol 2000 17 : 420.
37. Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol 2002 19 : 263 266. (Pubitemid 34625790)
38. Aldara (imiquimod cream, 5%) package insert. Bristol, TN : Graceway Pharmaceuticals LLC, 2007.
39. Roferon A (IFN alpha-2a) package insert copyright 1999-2008. Nutley, NJ : Hoffman-Laroche Roche Pharmaceuticals.